3M Acquires Acelity (and KCI) from Apax-led Consortium for $6.725B

Merck Acquires Acceleron Pharma for $11.5 Billion

September 30, 2021

Biotechnology

Merck has entered into a definitive agreement to acquire Acceleron Pharma Inc. for $180 per share in cash, representing an approximate total equity value of $11.5 billion. The acquisition brings Acceleron's late-stage sotatercept program (for pulmonary arterial hypertension) and its REBLOZYL portfolio into Merck's cardiovascular pipeline, subject to tender offer completion and customary regulatory approvals.

Altaris Capital Partners Acquires Kindeva Drug Delivery from 3M

May 1, 2020

Medical Devices

Altaris Capital Partners has acquired Kindeva Drug Delivery L.P. (formerly 3M Drug Delivery Systems) from 3M Company for $650 million in a corporate carve-out transaction. Monroe Capital provided financing and an equity co-investment to support the deal, and 3M will retain a minority interest alongside Altaris as Kindeva operates independently to pursue growth and capital investments.

3M Acquires M*Modal's Technology Business

December 19, 2018

Healthcare Services

3M has entered into a definitive agreement to acquire the technology business of M*Modal for an enterprise value of $1.0 billion, expanding 3M Health Information Systems' capabilities in conversational AI and clinical documentation. The acquired business, based in Pittsburgh, Pennsylvania, generates approximately $200 million in annual revenue and about 750 employees are expected to join 3M; M*Modal will retain its transcription, scribing and coding services business.

KCC Corporation to Fully Acquire Momentive Performance Materials Group

March 28, 2024

Manufacturing

KCC Corporation, the Seoul-based chemicals manufacturer, has entered into an agreement to fully acquire Momentive Performance Materials Group, consolidating ownership and resulting in the exit of minority shareholder SJL Partners LLC. The transaction, which remains subject to customary closing conditions, brings Momentive (a global silicones and specialty materials manufacturer headquartered in Niskayuna, New York) under 100% KCC ownership to support expanded collaboration and capability growth.

KKR to Acquire Healthium MedTech from Apax Funds

May 6, 2024

Medical Devices

KKR (through funds it manages) has signed definitive agreements to acquire a controlling interest in Healthium MedTech Ltd. from funds advised by Apax Partners. The transaction, expected to close in Q3 2024 subject to regulatory approvals, will support Healthium's next phase of global growth and product/market expansion.

Arcline Acquires Kaman Corporation for $1.8 Billion

January 19, 2024

Manufacturing

Arcline Investment Management has completed an all-cash acquisition of Kaman Corporation for a total enterprise value of approximately $1.8 billion, with Kaman shareholders receiving $46.00 per share. The transaction takes Kaman private and is intended to accelerate product development and strategic growth initiatives across Kaman's aerospace, industrial and medical businesses.